Fozard, J. R., 5-HT: The Enigma Variations, Trends Pharmacol. Sci. 1987; 8: 501-506. |
Drugs Acting on 5-Hydroxytryptamine Receptors, The Lancet, Sep. 23, 1989; pp. 717-719. |
Reynolds, J. C., Prokinetic Agents: A Key in the Future of Gastroenterology, Gastroenterology Clinics of North America, 1989; 18: 437-457. |
Peatfield, R., Drugs and the Treatment of Migraine, Trends Pharmacol. Sci. 1988; 9: 141-145. |
King, F. D. et al., 5-HT.sub.3 Receptor Antagonists, Drugs of the Future, 1989; 14: 875-889. |
Turconi, M. et al., Synthesis of a New Class of 2,3-Dihydro-2-oxo-1H-Benzimidazole-1-Carboxylic Acid Derivatives as Highly Potent 5-HT.sub.3 Receptor Antagonists, J. Med. Chem., 1990; 33: 2101-2108. |
Poletto, J. F. et al., Synthesis and Antiinflammatory Evaluation of Certain 5-Alkoxy-2,7-Dialkyltryptamines, J. Med. Chem., 1973; 16(7): 757-765. |
Nogrady et al., Indole Hydrazides as Potential Monoamine Oxidase Inhibitors, J. Med. Chem., 1966; 9: 438-439. |
Franke, A., Synthesis and Reactions of (o-Acylamino)Phenylglyoxylic Amides, Liebigs Ann. Chem., 1982; 4: 794-804. |